#HIV research

More than 300 organizations call for more funding for the National Institutes of Health.

The Campbell Foundation’s latest grant funds research into the RV144 trial in Thailand, which showed 31 percent protection against HIV.

The goal is an inexpensive point-of-care test that quickly determines an individual’s best treatment options.

Take a survey on HIV cure research.

It’s just one episode of “HIV Matters,” a (free!) podcast series from the University of North Carolina’s Department of Medicine.

An estimated 7,760 HIV-positive U.S. residents were diagnosed with cancer in 2010.

Scientists tested the effects of the broadly neutralizing antibody PGT121 and the immune-stimulating agent GS-9620 in monkeys.

Robert R. Redfield, MD, is a longtime HIV researcher. But he’s also controversial.

Merck’s investigational antiretroviral could one day be dosed only weekly among HIV-negative humans.

This long-acting drug is linked to undetectable viral loads in former prisoners with substance use disorders.

The CDC reports that PrEP use is low among Blacks and Latinos.

People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.

Two men claim they developed bone and kidney problems after taking TDF. A related class action lawsuit has also been filed.

Like HIV, HTLV-1 can be transmitted through blood and sex. It weakens the immune system and can cause death.

For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.

People living with HIV are not getting vaccinated for hepatitis B.